[{"id":"c5f8fab6-c86d-4fbe-a8fb-aecc5ef0282c","acronym":"","url":"https://clinicaltrials.gov/study/NCT02979366","created_at":"2021-01-18T14:39:22.062Z","updated_at":"2024-07-02T16:36:10.230Z","phase":"Phase 1","brief_title":"Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome","source_id_and_acronym":"NCT02979366","lead_sponsor":"Institut de Recherches Internationales Servier","biomarkers":" UGT1A1","pipe":" | ","alterations":" UGT1A1*1*1","tags":["UGT1A1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e UGT1A1*1*1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MIK665"],"overall_status":"Completed","enrollment":" Enrollment 38","initiation":"Initiation: 03/15/2017","start_date":" 03/15/2017","primary_txt":" Primary completion: 05/11/2020","primary_completion_date":" 05/11/2020","study_txt":" Completion: 05/11/2020","study_completion_date":" 05/11/2020","last_update_posted":"2022-05-18"}]